| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to field of medicine, in particular to pharmacology and represents a pharmaceutical composition with antipsychotic action, including as active ingredient therapeutically effective amount of methyl ether N-caproyl-L-prolyl-L-tyrosine, and as auxiliary substance, at least, one substance, selected from the group, including starch, lactose and auxiliary substances on its base, microcrystalline cellulose (MCC), aerosil, modified starches, calcium phosphate twice-substituted, polyvinyl pyrrolidone, methylcellulose, carboxymethylcellulose, and its sodium salt, oxypropylmethylcellulose, mannitol, sorbitol, stearic acid and/or its salt. ^ EFFECT: invention provides creation of neuroleptic, not depressing cognitive functions even improving them. ^ 19 cl, 25 ex, 3 tbl |
